From Conjecture to Clarity

Supporting the Healthcare Industry
with Local Industry Knowledge
and Marketing Expertise

Our Offerings

Pharmaceutical Sales Forecast & Project Valuation

Our clients are industry leaders who would like to make well-informed decisions about entering markets.

We help clients understand the Japanese market, recognize threats and opportunities and provide a clear idea of the value of their innovation in Japan.

Our services include

  • Forecasting models
  • P&L assumptions
  • Primary market research
  • Competitive landscape
  • Pricing Assumptions
Click here for details >

Pharmaceutical Pricing Consultation

The pricing of pharmaceuticals always presents a challenge for companies seeking to expand their footprint in new markets.

We provide a full range of pricing and market access consultations from the planning stage to post-commercialization.

Our clients are able to develop fully integrated global pricing strategies to maximize the value of their product.

Our services include

  • Forecasting Price Dynamics of New & Existing Products
  • Consultation, Participation and Representation in the Official Price Negotiation Process
  • In-Depth Interviews with MLHW Officials
Click here for details >

Business Development Support

We support clients seeking to partner with Japanese companies.

e-Projection’s deep engagement in the industry network space differentiates us from any other vendor of the kind.

We are widely recognized for our knowledge of the local market and support the negation process by quantifying the value of the asset in a convincing manner.

We also have a network in China and can support those clients who additionally want to partner with Chinese companies.

Our services include

  • Target Screening & Identification
  • Approach to Initiate Communication
  • Due Diligence
  • Term Sheet Negotiation
  • Approach to Initiate Communication
  • Alliance Management
Click here for details >

We help non-Japanese pharma/biotech companies understand and expand into the Japanese market.


  • 2021.03.10

    To the last drop

    Allowing 7 shots per vial of Pfizer’s covid vaccine may wreak havoc to the already problematic Japanese immunization program Mottainai is one of the virtues of Japanese culture which means avoiding waste and making use of all that is available, especially in a country without significant natural resources. Yesterday, this sense of savings was taken […]

  • 2021.03.03

    Not going viral enough

    MSD’s Silgard 9 silently reaches the market after five years of regulatory turmoil and social aversion against immunization While the covid-19 vaccine is the only thing people talk about, last week another type of jab has been launched in the Japanese market. MSD, a multinational pharmaceutical company which is known as Merck and Co. in […]

  • 2020.12.08

    e-Projection is going to Biotech Showcase Digital 2021!

    Join us in the virtual space this time, to discuss about your strategy to expand your business globally.

  • 2020.12.07

    Exploring the Right Size of Our Team

    Last month we were blessed by being joined with two great talents as full-time employees. In just a couple of years, the size of our squad has been rapidly increasing with both members showing full commitment in our operations and key industrial experts among various disciplines joining our advisory board. At the time I embarked […]

  • 2019.06.18

    Appeal of the Japanese Market

    Our publication is referenced in Lacerta Bio’s blog on the Japanese Market. Have We Forgotten About Japan?  

We help non-Japanese pharma/biotech companies understand and expand into the Japanese market.